114 Followers on Owler
OverviewCompetitorsFundingNews & Insights

PhaseBio Competitors or Alternatives

PhaseBio's top competitors include Acer, Altimmune and Amicus.

Unlock 23 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

PhaseBio's company profile

Jonathan Mow

CEO

88/100
60
$204.1M
$ < 1M
  • $204.1M
    $ < 1M
  • 60
    $204.1M
  • $ < 1M
  • 88/100
  • 60
  • $204.1M
  • $ < 1M
View ProfileView
1
PhaseBio's Competitor - Acer logo

Chris Schelling

Founder & CEO

88/100
25 - 100
$96.6M
$100K - 5M
  • $96.6M
    $100K - 5M
  • 25 - 100
    $96.6M
  • $100K - 5M
  • 88/100
  • 25 - 100
  • $96.6M
  • $100K - 5M
View ProfileView
2
PhaseBio's Competitor - Altimmune logo

Vipin K. Garg

President & CEO

86/100
50
$220.6M
$ < 1M
  • $220.6M
    $ < 1M
  • 50
    $220.6M
  • $ < 1M
  • 86/100
  • 50
  • $220.6M
  • $ < 1M
View ProfileView
3
PhaseBio's Competitor - Amicus logo

Bradley L Campbell

President & CEO

82/100
480
$1.3B
$528.3M
  • $1.3B
    $528.3M
  • 480
    $1.3B
  • $528.3M
  • 82/100
  • 480
  • $1.3B
  • $528.3M
View ProfileView
4
PhaseBio's Competitor - Agilis Biotherapeutics logo

Mark J. Pykett

President & CEO

82/100
25 - 100
$20.7M
$100K - 5M
  • $20.7M
    $100K - 5M
  • 25 - 100
    $20.7M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $20.7M
  • $100K - 5M
View ProfileView
5
PhaseBio's Competitor - Sangamo logo

Sandy Macrae

President & CEO

68/100
480
$71.5M
$57.8M
  • $71.5M
    $57.8M
  • 480
    $71.5M
  • $57.8M
  • 68/100
  • 480
  • $71.5M
  • $57.8M
View ProfileView
PhaseBio's top 26 competitors are Acer, Altimmune, Amicus, PanOptica, Agilis Biotherapeutics, Sangamo, Astellas, Bayer , Selecta, Horizon Therapeutics, Sanofi, Veru, Takeda Pharmaceutical, Inovio, bluebird bio, Ocular, Aytu, VBI, Attune, Actinium, Idorsia, Atreca, MacuCLEAR, Protalix, Spark Therapeutics and Immedica. Together they have raised over 14.1B between their estimated 253.3K employees. PhaseBio has 60 employees and is ranked 21th among it's top 10 competitors. The top 10 competitors average 9,382.

PhaseBio VS Acer

Acer has been one of PhaseBio's top competitors. Acer is a Private company that was founded in 2013 in Newton, Massachusetts. Like PhaseBio, Acer also competes in the Pharmaceuticals sector. Compared to PhaseBio, Acer has 30 fewer employees.

PhaseBio VS Altimmune

Altimmune is seen as one of PhaseBio's biggest rivals. Altimmune is a Public company that was founded in Gaithersburg, Maryland in 1997. Like PhaseBio, Altimmune also operates in the Pharmaceuticals sector. Altimmune has 10 fewer employees vs. PhaseBio.

PhaseBio VS Amicus

Amicus is perceived as one of PhaseBio's biggest rivals. Amicus was founded in Princeton, New Jersey} in 2002. Like PhaseBio, Amicus also competes in the Biotechnology space. Compared to PhaseBio, Amicus generates $527.7M more revenue.

Looking for similar companies to PhaseBio?

Similar Companies

Pharmaceuticals companies in Malvern

See 19 companies 
Pharmaceuticals companies in Delaware Valley

See 441 companies 
Pharmaceuticals & Biotechnology companies in Malvern

See 38 companies 
Biotechnology companies in Delaware Valley

See 392 companies 
Biotechnology companies in Malvern

See 22 companies 
Biotechnology companies in Pennsylvania

See 442 companies 
Pharmaceuticals companies in Pennsylvania

See 464 companies 
Companies in Malvern with revenue in $5.0-25M range

See 570 companies 
Companies in Malvern with employees in 25-100 range

See 687 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for PhaseBio and PhaseBio's Competitors

April 16, 2025Zacks
SNY shares preliminary data from phase II study on amlitelimab in moderate-to-severe asthma. It also provides updates on lunsekimig and itepekimab stud...
April 15, 2025Pharmabiz
Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, announced a collaboration agreement with Astellas Pharma,...
April 16, 2025Benzinga
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharma...
April 16, 2025Pharmaceutical Processing World
Bayer announced today that it opened a 70,000-square-foot expansion at its Myerstown, Pennsylvania, facility. The grand opening of the state-of-the-art...
April 16, 2025StreetInsider
MIAMI, FL, April 16, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovativ...
April 15, 2025IndiaMedToday
In a move that could redefine India's insulin market, Sanofi is quietly preparing to sell its blockbuster brand Lantus, signalling a turning point in t...
April 15, 2025Benzinga
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Actinium Pharmaceuticals, Inc. ATNM . Sh...
April 15, 2025Benzinga
Sanofi SA (NASDAQ:SNY) on Tuesday shared progress from its mid- to late-stage respiratory pipeline.The French drug maker reported preliminary results f...
April 16, 2025BioSpace
Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants ...
April 15, 2025Endpoints News
Sanofi's efforts to explore its OX40-ligand targeting drug for inflammatory diseases other than eczema have hit a roadblock as the drug failed a Phase ...

Frequently Asked Questions about PhaseBio

  1. Who are PhaseBio's top competitors?

    PhaseBio's top 3 competitors are Acer, Altimmune, Amicus.

  2. Who is similar to PhaseBio?

    Acer is the most similar to PhaseBio. Altimmune and Amicus are also similar to PhaseBio.

  1. Are PhaseBio and Acer competitors?

    Yes, Acer is one of PhaseBio’s top competitors.